Identification of the major site of O-linked β-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1

Molecular and Cellular Proteomics

Volumn 5, Issue 2, 2006, Pages 313-323

  Ball, Lauren E ^a   Berkaw, Mary N ^a   Buse, Maria G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLGLUCOSAMINE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MONOSACCHARIDE; N ACETYL BETA GLUCOSAMINIDASE; SERINE; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; DERIVATIZATION; HUMAN; HUMAN CELL; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

ACETYLGLUCOSAMINE; AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, LIQUID; GLUCOSE; INSULIN; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PEPTIDE MAPPING; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECOMBINANT PROTEINS; SERINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THREONINE; TRYPSIN;

EID: 33644698706     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500314-MCP200     Document Type: Article

References (41)

1. Hart, G. W. (1997) Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem. 66, 315-335
2. Comer, F. I., and Hart, G. W. (2001) Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40, 7845-7852
3. Slawson, C., and Hart, G. W. (2003) Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation. Curr. Opin. Struct. Biol. 13, 631-636
4. Iyer, S. P., and Hart, G. W. (2003) Dynamic nuclear and cytoplasmic glycosylation: enzymes of O-GlcNAc cycling. Biochemistry 42, 2493-2499
5. Shafi, R., Iyer, S. P., Ellies, L. G., O'Donnell, N., Marek, K. W., Chui, D., Hart, G. W., and Marth, J. D. (2000) The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 97, 5735-5739
6. Marshall, S., Bacote, V., and Traxinger, R. R. (1991) Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266, 4706-4712
7. McClain, D. A. (2002) Hexosamines as mediators of nutrient sensing and regulation in diabetes. J. Diabetes Complicat. 16, 72-80
8. Ludemann, N., Clement, A., Hans, V. H., Leschik, J., Behl, C., and Brandt, R. (2005) O-Glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J. Biol. Chem. 280, 31648-31658
9. Hu, Y., Belke, D., Suarez, J., Swanson, E., Clark, R., Hoshijima, M., and Dillmann, W. H. (2005) Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ. Res. 96, 1006-1013
10. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., and Gong, C. X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 101, 10804-10809
11. Vosseller, K., Wells, L., Lane, M. D., and Hart, G. W. (2002) Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. U. S. A. 99, 5313-5318
12. Federici, M., Menghini, R., Mauriello, A., Hribal, M. L., Ferrelli, F., Lauro, D., Sbraccia, P., Spagnoli, L. G., Sesti G., and Lauro, R. (2002) Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endotheliall cells. Circulation 106, 466-472
13. Patti, M. E., Virkamaki, A., Landaker, E. J., Kahn, C. R., and Yki-Jarvinen, H. (1999) Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48, 1562-1571
14. White, M. F. (2002) IRS proteins and the common path to diabetes. Am. J. Physiol. 283, E413-E422
15. Gual, P., Le Marchand-Brustel, Y., and Tanti, J. F. (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie (Paris) 87, 99-109
16. Haynes, P.A., and Aebersold, R. (2000) Simultaneous detection and identification of O-GlcNAc-modified glycoproteins using liquid chromatography-tandem mass spectrometry. Anal. Chem. 72, 5402-5410
17. Chalkley, R. J., and Burlingame, A. L. (2003) Identification of novel sites of O-N-acetylglucosamine modification of serum response factor using quadrupole time-of-flight mass spectrometry. Mol. Cell. Proteomics 2, 182-190
18. Greis, K. D., Hayes, B. K., Comer, F. I., Kirk, M., Barnes, S., Lowary, T. L., and Hart, G. W. (1996) Selective detection and site-analysis of O-GIc-NAc-modified glycopeptides by β-elimination and tandem electrospray mass spectrometry. Anal. Biochem. 234, 38-49
19. Schroeder, J., Webb, D. J., Shabanowitz, J., Horwitz A. F., and Hunt, D. F. (2005) Methods for the detection of paxillin post-translational modifications and interacting proteins by mass spectrometry. J. Proteome Res. 4, 1832-1841
20. Gao, Y., Miyazaki, J., and Hart, G. W. (2003) The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch. Biochem. Biophys. 415, 155-163
21. Wells, L., Vosseller, K., Cole, R. N., Cronshaw, J. M., Matunis, M. J., and Hart, G. W. (2002) Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell. Proteomics 1, 791-804
22. Roquemore, E. P., Chou, T. Y., and Hart, G. W. (1994) Detection of O-linked N-acetylglucosamine (O-GlcNAc) on cytoplasmic and nuclear proteins. Methods Enzymol. 230, 443-460
23. Sprung, R., Nandi, A., Chen, Y., Kim, S. C., Barma, D., Falck, J. R., and Zhao, Y. (2005) Tagging-via-substrate strategy for probing O-GlcNAc modified proteins. J. Proteome Res. 4, 950-957
24. Khidekel, N., Ficarro, S. B., Peters, E. C., and Hsieh-Wilson, L. C. (2004) Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. Proc. Natl. Acad. Sci. U. S. A. 101, 13132-13137
25. Vocadlo, D. J., Hang, H. C., Kim, E. J., Hanover, J. A., and Bertozzi, C. R. (2003) A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc. Natl. Acad. Sci. U. S. A. 100, 9116-9121
26. Medzihradszky, K. F., Darula, Z., Perlson, E., Fainzilber, M., Chalkley, R. J., Ball, H., Greenbaum, D., Bogyo, M., Tyson, D. R., Bradshaw, R. A., and Burlingame, A. L. (2004) O-Sulfonation of serine and threonine: mass spectrometric detection and characterization of a new posttranslational modification in diverse proteins throughout the eukaryotes. Mol. Cell. Proteomics 3, 429-440
27. Mirgorodskaya, E., Hassan, H., Clausen, H., and Roepstorff, P. (2001) Mass spectrometric determination of O-glycosylation sites using β-elimination and partial acid hydrolysis. Anal. Chem. 73, 1263-1269
28. Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., and White, M. F. (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77
29. Haltiwanger, R. S., Grove, K., and Philipsberg, G. A. (1998) Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-β-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem. 273, 3611-3617
30. McLachlin, D. T., and Chait, B. T. (2003) Improved β-elimination-based affinity purification strategy for enrichment of phosphopeptides. Anal. Chem. 75, 6826-6836
31. Eng, J., McCormack, A. L., and Yates, J. R. (1994) An approach to correlated tandem mass spectral data of peptides with a sequence in a protein database. J. Am. Soc. Mass Spectrom. 5, 976-989
32. Taylor, J. A., Walsh, K. A., and Johnson, R. S. (1996) Sherpa: a Macintosh-based expert system for the interpretation of electrospray ionization LC/MS and MS/MS data from protein digests. Rapid Commun. Mass Spectrom. 10, 679-687
33. 178, a site required for 14-3-3 binding. J. Biol. Chem. 279, 10176-10184
34. Comer, F. I., Vosseller K., Wells, L., Accavitti, M. A., and Hart, G. W. (2001) Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 293, 169-177
35. Luo, M., Reyna, S., Wang, L., Yi, Z., Carroll, C., Dong, L. Q., Langlais, P., Weintraub, S. T., and Mandarino, L. J. (2005) Identification of IRS-1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223. Endocrinology 146, 4410-4416
36. Vosseller, K., Hansen, K. C., Chalkley, R. J., Trinidad, J. C., Wells, L., Hart, G. W., and Burlingame, A. L. (2005) Quantitative analysis of both protein expression and serine/threonine post-translational modifications through stable isotope labeling with dithiothreitol. Proteomics 5, 388-398
37. Myers, M. G., Jr., Mendez, R., Shi, P., Pierce, J. H., Rhoads, R., and White, M. F. (1998) The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J. Biol. Chem. 273, 26908-26914
38. 307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277, 1531-1537
39. Greene, M. W., Morrice, N., Garofalo, R. S., and Roth, R. A. (2004) Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cδ. Biochem. J. 378, 105-116
40. Mothe, I., and Van Obberghen, E. (1996) Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271, 11222-11227
41. 1101. J. Biol. Chem. 279, 45304-45307